S. Neidhart

Swiss Epilepsy Center

Papers

1

Total Citations

2

H-Index

1

About

S. Neidhart is a clinical researcher whose work focuses on advanced neuromodulation therapies for drug-resistant epilepsy, particularly in rare and challenging conditions like Lennox-Gastaut Syndrome (LGS). Their most notable contribution is a pioneering 2024 single case study demonstrating that directional deep brain stimulation (DBS) of the centromedian thalamic nucleus can significantly reduce debilitating side effects—specifically ataxia and dysarthria—while maintaining seizure control. This work addresses a critical gap in epilepsy care, where traditional DBS often trades seizure reduction for motor and speech impairments. Though early in its citation impact (2 citations), the study’s clinical innovation is substantial: it introduces a personalized, robotically assisted approach that refines stimulation fields to spare adjacent motor pathways. Neidhart’s research exemplifies the growing trend toward precision neuromodulation, offering hope for improved quality of life in patients with refractory epilepsy. Their work is especially relevant for clinicians and researchers exploring how directional steering and patient-specific targeting can optimize DBS outcomes, making them a rising voice in the field of functional neurosurgery and epilepsy management.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Directional deep brain stimulation of the centromedian thalamic nucleus reduces DBS-induced ataxia and dysarthria in Lennox-Gastaut Syndrome: A single case study
2 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 3
🏛 Institutions: Swiss Epilepsy Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago